Content Validity

Fair Balance *

• The content is balanced in its discussion of therapeutic options.
• I have concerns about balance that I will describe below.

Does the content and presentation of a drug’s most important risks must be reasonably similar to the content and presentation of its benefits? This does not mean that equal space must be given to risks and benefits in print ads, or equal time to risks and benefits in broadcast ads.Comments Brand Names vs Trade Names *

• The content does not include mention of a proprietary healthcare product (drug, device, OTC item, test, vaccine, etc.)
• The content includes generic names when describing a drug AND/OR trade names from two or more companies.
• The content addresses nonclinical topics.
• Unsure – request additional review.
• I have concerns that I will describe below.

Comments Commercial Bias or Evidence of Marketing *

• The content does not include commercial bias.
• I have concerns that I will describe below.

Does the content include logos from drug or device companies? Are there trademark, copyright, service marks present? Does the content promote a particular company or proprietary interest?Comments Scientific Rigor *

• The content is scientifically rigorous.
• I have concerns that I will describe below.

– Are clinical studies cited from credible sources, eg, peer-reviewed journals?
– Does it discuss concepts in terms of generally accepted standards of experimental design, data collection, analysis, and interpretation?
– Does the content advocate for unscientific approaches to diagonsis or therapy?
– Does the content include promote recommendations, treatments, or manners of practicing healthcare that have risks or dangers that outweigh the benefits OR are known to be ineffective in the treatment of patients?Comments Meeting Learning Objectives *

• The content supports the activity’s learning objective(s).
• I have concerns that I will describe below.

Comments The content I reviewed meets the expectations for the continuing professional development of healthcare professionals. It includes 'A range of learning activities through which health professionals maintain and develop throughout their careers to ensure that they retain their capacity to practice safely, effectively, and legally within their evolving scope of practice.' (NIH) *

• The content is appropriate for clinicians.
• I have concerns that I will describe below.

Content addresses topics relevant to clinical practice, practice management, research and educational methodologies, coding practices, etc.)
Nonclinical topics such as personal finance do not meet this expectation.Additional Comments or ObservationsReview Completed on this Date
Submit